The Latest on What MedTech Commercial Teams Need to Know About the 2026 CPT Code Changes
July 28, 2026
The 2026 CPT update introduces one of the largest sets of coding changes in recent years, with major implications for cardiovascular, orthopedic, neurosurgery, hearing devices, and AI-enabled technologies.
Every year, the American Medical Association's CPT Editorial Panel updates the code set that determines how medical services and procedures get reported, billed, and reimbursed across the U.S. healthcare system. For most commercial teams, that annual update registers as background noise. A handful of new codes, a few deletions, business as usual. 2026 is not business as usual.
In January 2026, the CPT code set absorbed 418 total changes: 288 new codes, 84 deletions, and 46 revisions. By any measure, this ranks among the largest single-cycle updates on record.
A meaningful share of those changes land directly in the categories that matter most to MedTech commercial teams: cardiovascular, orthopedic, neurosurgery, hearing devices, and an expanding new category purpose-built for AI-enabled and digital health services.
This is not a compliance exercise. It is a commercial signal.
ICYMI: here's a walk-through of what's changing, who it affects, and how to think about it for the rest of the year.
A quick refresher on how CPT works
CPT (Current Procedural Terminology) codes are the common language that lets a physician, an ASC, and a payer all describe the same procedure the same way. They're organized into four areas:
- Category I — the core set (00100–99499), covering the vast majority of procedures and services.
- Category II — optional, supplemental codes used for performance tracking, not required for correct coding.
- Category III — temporary codes for new and emerging technology. These exist so CMS and other payers can start collecting utilization data on a new procedure before it's proven enough volume to "graduate" into a permanent Category I code.
- PLA (Proprietary Laboratory Analyses) codes — a newer category covering proprietary lab tests, including Advanced Diagnostic Laboratory Tests and Clinical Diagnostic Laboratory Tests defined under PAMA.
That Category III pathway matters for how to read this year's update: nearly a quarter of the new codes are Category III, which is a signal about where new technology is currently sitting in the adoption curve, not necessarily where it's already generating steady volume.
Where the 2026 changes concentrate
Looking at the 288 new codes, two categories stand out disproportionately: Proprietary Lab Analyses (27%) and Category III temporary/emerging-technology codes (27%). Together, more than half of everything new this year is either a novel lab test or an unproven technology still building its evidence base. The remaining 46%, however, spans the more familiar categories below.
Cardiovascular: a shift toward bundling
This is one of the most structurally significant changes in the update. Coronary intervention and lower-extremity revascularization are both moving to territory-based, bundled coding — a single code now covers stent placement, angioplasty, and atherectomy together, organized by vascular territory (iliac, femoropopliteal, tibial-peroneal) rather than by device or technique. Lower extremity revascularization alone picks up 46 new codes under this model.
Several legacy codes are going away as part of this shift, including 33884 (proximal extension prosthesis placement) and the 37229–37235 range, both being folded into new, broader code families. Companies with products tied to the old, unbundled coding structure should take a close look at how their procedures map to the new territory-based codes.
Orthopedic: targeted deletions
The orthopedic changes are narrower in scope but must still be flagged. Knee arthroplasty using a hinge prosthesis (27445) is deleted, with volume shifting to 27447 and 27487 under 2026 reporting criteria.
A handful of lower-volume codes, including combined femoral osteoplasty (27468), are deleted with no direct replacement, reflecting procedures that had already fallen out of clinical favor.
Neurosurgery: temporary codes graduating
Several Category III codes are "graduating" into permanent status this year, which is exactly what that temporary designation is designed to enable. Baroreflex Activation Therapy (formerly 0266T–0273T) moves to permanent codes 64654–64659 and 93145–93146. Percutaneous electrical nerve field stimulation of cranial nerves also gets a permanent home at 64657.
Hearing devices: built for how care is actually delivered now
Twelve new codes (92628 through 92642) replace the old analog hearing aid codeset (92590 through 92595) in one clean sweep. The new codes explicitly account for digital and programmable devices, and for the first time reimburse for validation, performance checks, and patient training as distinct billable services.
Built with teleaudiology and smartphone-integrated devices in mind, this is not a routine refresh but a codeset finally catching up to clinical and technological reality.
Radiation therapy: reporting catches up with modern delivery
CPT codes 77385 and 77386, longstanding codes for IMRT delivery, have been deleted. In their place comes a restructured codeset built around advanced planning techniques, delivery complexity and technology-driven workflows.
The old codes reflected an outdated approach and the replacements are grounded and built for how the field actually operates today.
The category to watch: AI and augmentative service codes
Perhaps the clearest signal in this update is the number of new codes built specifically for AI-enabled and augmentative services — coronary atherosclerotic plaque assessment, perivascular fat analysis for cardiac risk, multi-spectral imaging for burn wounds, and cardiac dysfunction detection all get dedicated codes for the first time. This is the CPT Editorial Panel formally recognizing that AI-assisted interpretation and augmentation is now common enough in clinical practice to need its own reporting language — a milestone worth watching regardless of which specialty you focus on.
What this means moving forward
For commercial and marketing teams, there are some key actions to prioritize:
- Update your code set mappings. Any product associated with a deleted or bundled code needs a clear answer for how it reports going forward - and your reps need that answer before a customer asks for it, not after.
- Identify who's actually affected. Some changes (like the cardiovascular bundling) ripple across broad swaths of a specialty. Others are narrow enough that only a handful of accounts will feel them. Knowing which is which is what separates a prioritized, targeted outreach plan from a scramble.
Getting this right can mean combing through code sets manually account by account - work that's easy to get wrong under time pressure.
If this sounds intimidating, reach out to us so we can show you how the AcuityMD platform can help – and AcuityMD customers can grab a free 1-hour consult with our in-house clinical coding experts.
Source note: code-level detail in this post is drawn from the American Medical Association, Find-A-Code, and CCO Academy's 2026 CPT update coverage.